Supplementary Figure 2: Effect of SL on the growth of HUVECs stimulated by VEGF. (A-G)
The HUVECs were treated with or without SL (30 μM) in the presence or absence of VEGF (50 ng/ml) for the indicated times. The viabilities of HUVECs were evaluated by 5-bromo-2-deoxyuridine (BrdU) cell proliferation assay (BioVision, CA, USA). At the end of the in vivo allograft experiment, blood of each mouse was collected from the retro-orbital plexus, and then the sera from blood were prepared. To investigate the toxicity of SL on liver and kidney of mice, biochemical analysis on the aspartate aminotransferase (AST), alanine aminotransferase (ALT), creatinine, and blood urea nitrogen (BUN) were performed by commercial service by Green Cross Co. (Yongin, Korea).
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